fbpx

Sensing & Smart Monitoring

The research area Sensing & Smart Monitoring aims to improve the management of diabetes with the help of new innovative sensor solutions.

The currently available measuring systems – so-called continuously measuring glucose sensors – determine the glucose concentration in the tissue fluid under the skin. These glucose values are delayed by several minutes compared to the actual blood glucose values. Glucose levels in the blood can change rapidly due to activity, food intake, hormone fluctuations or illness. This pushes current glucose sensors to their limits and complicates systems that depend on this measurement – for example, systems for automated insulin delivery. To enable these systems for completely automated insulin delivery (so-called “closed-loop systems” or “artificial pancreases”), new sensors are needed that measure the glucose level in the blood in real time, i.e. without delay.

For the glucose sensors, different optical methods are combined that measure the glucose concentration directly in the blood. Furthermore, this research area deals with alternative methods for detecting glucose levels through minimally invasive and non-invasive technologies in combination with the measurement of physiological parameters, such as heart rate variability, respiration, blood pressure and activity. To enable patient-specific diagnosis and treatment, sensors for measuring hormones, ketone bodies, lipids and lactate are also of interest. By using smart algorithms, different parameters can be combined and confounding factors can be factored out.

Projects in this focus area

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland